These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


186 related items for PubMed ID: 1386313

  • 1. Immunobiological studies on experimental visceral leishmaniasis. II. Adherent cell-mediated down-regulation of delayed-type hypersensitivity response and up-regulation of B cell activation.
    Basak SK, Saha B, Bhattacharya A, Roy S.
    Eur J Immunol; 1992 Aug; 22(8):2041-5. PubMed ID: 1386313
    [Abstract] [Full Text] [Related]

  • 2. Distinct subsets of accessory cells activate Thy-1+ triple negative (CD3-, CD4-, CD8-) cells and Th-1 delayed-type hypersensitivity effector T cells.
    Matsushima GK, Stohlman SA.
    J Immunol; 1991 May 15; 146(10):3322-31. PubMed ID: 1673982
    [Abstract] [Full Text] [Related]

  • 3. Macrophage-T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania-infected macrophages and its implication in the suppression of cell-mediated immunity.
    Saha B, Das G, Vohra H, Ganguly NK, Mishra GC.
    Eur J Immunol; 1995 Sep 15; 25(9):2492-8. PubMed ID: 7589116
    [Abstract] [Full Text] [Related]

  • 4. Macrophage-T cell interaction in experimental mycobacterial infection. Selective regulation of co-stimulatory molecules on Mycobacterium-infected macrophages and its implication in the suppression of cell-mediated immune response.
    Saha B, Das G, Vohra H, Ganguly NK, Mishra GC.
    Eur J Immunol; 1994 Nov 15; 24(11):2618-24. PubMed ID: 7525297
    [Abstract] [Full Text] [Related]

  • 5. Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection.
    Varkila K, Chatelain R, Leal LM, Coffman RL.
    Eur J Immunol; 1993 Jan 15; 23(1):262-8. PubMed ID: 8419179
    [Abstract] [Full Text] [Related]

  • 6. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
    Miller SD, Butler LD.
    J Immunol; 1983 Jul 15; 131(1):77-85. PubMed ID: 6190929
    [Abstract] [Full Text] [Related]

  • 7. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
    Mazumdar T, Anam K, Ali N.
    Vaccine; 2004 Mar 12; 22(9-10):1162-71. PubMed ID: 15003644
    [Abstract] [Full Text] [Related]

  • 8. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA, Ogunremi O, Menon JN.
    Behring Inst Mitt; 1997 Feb 12; (98):153-9. PubMed ID: 9382736
    [Abstract] [Full Text] [Related]

  • 9. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
    Titus RG, Lima GC, Engers HD, Louis JA.
    J Immunol; 1984 Sep 12; 133(3):1594-600. PubMed ID: 6205088
    [Abstract] [Full Text] [Related]

  • 10. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones.
    Cher DJ, Mosmann TR.
    J Immunol; 1987 Jun 01; 138(11):3688-94. PubMed ID: 2953788
    [Abstract] [Full Text] [Related]

  • 11. Is the delayed-type hypersensitivity observed after a low dose of antigen mediated by helper T cells?
    Milon G, Marchal G, Seman M, Truffa-Bachi P, Zilberfarb V.
    J Immunol; 1983 Mar 01; 130(3):1103-7. PubMed ID: 6218199
    [Abstract] [Full Text] [Related]

  • 12. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway.
    Sacks DL, Scott PA, Asofsky R, Sher FA.
    J Immunol; 1984 Apr 01; 132(4):2072-7. PubMed ID: 6230400
    [Abstract] [Full Text] [Related]

  • 13. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
    Liew FY, Howard JG, Hale C.
    J Immunol; 1984 Jan 01; 132(1):456-61. PubMed ID: 6228580
    [Abstract] [Full Text] [Related]

  • 14. Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function.
    Cua DJ, Coffman RL, Stohlman SA.
    J Immunol; 1996 Oct 01; 157(7):2830-6. PubMed ID: 8816386
    [Abstract] [Full Text] [Related]

  • 15. Factors influencing the host response to Leishmania mexicana.
    Pérez H.
    Ciba Found Symp; 1983 Oct 01; 99():157-73. PubMed ID: 6227462
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunoregulatory pathways in adult responder mice. III. Establishment of a GAT-specific suppressor T cell clone from GAT-tolerant responders which afferently regulates DTH responses.
    Jenkins MK, Miller SD.
    J Mol Cell Immunol; 1985 Oct 01; 2(1):1-13. PubMed ID: 2978221
    [Abstract] [Full Text] [Related]

  • 20. Isotype-like suppression of T cell-mediated immunity in vivo. I. Delayed-type hypersensitivity specificity of T cell suppression induced by antigen-binding T cell factors that initiate contact sensitivity.
    Ptak W, Bereta M, Ptak M, Askenase PW.
    J Immunol; 1986 Mar 01; 136(5):1554-63. PubMed ID: 2419404
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.